Psychedelic Medicines in Major Depression: Progress and Future Challenges Read More > January 1, 2021
Apnea during slow sub-anaesthetic infusion of intravenous ketamine for treatment-resistant depression Read More > December 23, 2020
Ketamine as an adjunctive therapy for major depression – a randomised controlled pragmatic pilot trial (Karma-Dep Trial) Read More > December 16, 2020
Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study Read More > December 11, 2020
Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression Read More > December 11, 2020
Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation Read More > December 10, 2020
Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine Read More > December 10, 2020
Modulation of the functional connectome in major depressive disorder by ketamine therapy Read More > December 3, 2020
Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence Read More > December 3, 2020
